Guy Caljon

52PUBLICATIONS
178CO-AUTHORS
Characterisation of biological macromoleculesCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesBiomolecular modelling and designToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Sep 01, 2026
Late-Stage Diversification of Rewired Purine C-Nucleosides Reveals Potent Antitrypanosomatid Agents with In Vivo Efficacy.

|Jun 17, 2026
5‑Nitrofuran-Semicarbazone Hybrids as Antitrypanosomal Agents: Structure-Activity Relationship and Nitroreductase Activation.

|May 11, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate.

|May 05, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 1: setting the stage.

|Mar 31, 2026
A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit.

Sarah Hendrickx, Kayhan Ilbeigi, Eli S J Thoré

|Oct 29, 2025
Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties.

Nicolò Filippi, Kathleen Mertens, Joni De Loose

Pageof 9

Frequent Collaborators

14 joint publications

Louis Maes

9 joint publications

An Matheeussen

6 joint publications

Dorien Mabille

6 joint publications

Serge Van Calenbergh